Submit or Track your Manuscript LOG-IN

Seroprevalence of Toxoplasma gondii in Pregnant and Non-Pregnant Women of Khyber Pakhtunkhwa, Pakistan

PJZ_55_5_2173-2180

Seroprevalence of Toxoplasma gondii in Pregnant and Non-Pregnant Women of Khyber Pakhtunkhwa, Pakistan

Kiran Afshan1*, Sobia Baseer1, Shanza Kiran1, Ghulam Narjis2 and Sabika Firasat1

1Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan

2Department of Statistics, Faculty of Natural Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan

ABSTRACT

Toxoplasma gondii is a globally found intracellular parasite that infected a large proportion of the world population, it remained asymptomatic in immunocompetent patients but the acquisition of the infection during pregnancy can lead to abortions and other congenital defects. The present study aimed to find the seroprevalence of T. gondii among suspected women who visited local hospitals in Khyber Pakhtunkhwa (KP), Pakistan. Sera of 425 suspected women were screened by latex agglutination test (LAT) and enzyme-linked immunosorbent assay (ELISA) was performed to measure the IgG and IgM antibodies level. Univariate analysis and odds ratios were calculated to determine the strength of association. The overall T. gondii infection was 60% with LAT, 52% IgG, and 56.26% with IgM ELISA. The seroprevalence was 7.2%-15% among the five study districts of KP province. The toxoplasmosis was found significantly (p<0.001) higher in 34.7% to 44.2% of pregnant women as compared to non-pregnant. The high prevalence of infection was recorded among women belonging to the 20-30 years and 31-40 years age group (16.78%-36.45), 1st and 3rd trimesters (33.2%- 40.3%), and housewives (28.8%-37.4%). The mean of IgG and IgM antibodies titer was observed higher than >1.3 in pregnant women and in the 2nd and 3rd trimesters. The present study concluded a higher prevalence of T. gondii infection in women of childbearing age in KP, Pakistan, and requires preventive measures to reduce the abortion risks and congenital abnormalities in fetus.


Article Information

Received 14 February 2022

Revised 18 May 2022

Accepted 01 June 2022

Available online 01 August 2022

(early access)

Published 28 July 2023

Authors’ Contribution

KA designed the study. SB and SK performed the experiment. GN and SF advised on methods, experimentation, and interpretation of findings. SB, SK and KA conducted literature search, data analysis and manuscript preparation. KA and SF reviewed the manuscript. All authors participated in the study and concurred with the submission and subsequent revisions submitted by the corresponding author.

Key words

Toxoplasma gondii, LAT, ELISA, Pregnant women

DOI: https://dx.doi.org/10.17582/journal.pjz/20220214060241

* Corresponding author: kafshan@qau.edu.pk

0030-9923/2023/0005-2173 $ 9.00/0

Copyright 2023 by the authors. Licensee Zoological Society of Pakistan.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).



INTRODUCTION

Toxoplasma (T.) gondii, is an obligate intracellular parasite belonging to phylum Apicomplexa, is a zoonotic protozoan that infects warm-blooded animals including humans (Weiss and Dubey, 2009). People get the disease by the oral route through the utilization of half-cooked meat containing cysts, food items, or water polluted with oocysts (Tenter et al., 2000). The pregnant ladies infected may cause medical issues if the parasite is transmitted to the baby to cause congenital toxoplasmosis (Koneman et al., 2004). Congenital toxoplasmosis may cause abortion, neonatal death, or fetal anomalies with hindering ramifications for the fetus (Koneman et al., 2004).

Toxoplasma gondii accounts for a critical health hazard where the household cleanliness, dietary propensities, and disinfection are poor. Toxoplasma gondii is a cosmopolitan parasite with a variable recurrence rate around the globe (Tenter et al., 2000). Toxoplasmosis has infected one-third of the world’s human populace (Dubey, 2008). The predominance of T. gondii varies from less than 10% to 80% (Robert-Gangneux and Dardé, 2012). Considering, seroepidemiological studies, a higher prevalence of 50% has been recorded in America, the Middle East, and sub-Sahara Africa (Agmas et al., 2015; Varella et al., 2009). However, in Pakistan so far recorded seroprevalence was 25.8% in Punjab (Shahzad et al., 2020), 40.6% in Mardan, KP (Rahman et al., 2021), and 20.37% in sub-tropical regions of Pakistan (Ahmad et al., 2019).

The serological detection methods used for T. gondii determine the phase of infection i.e., the chronic or acute stage (Hadi et al., 2016). Sabin-Feldman dye test was the most reliable test for T. gondii and viewed as the gold standard. However, the limitation of the assay was the utilization of live organisms and human serum from healthy people as a frill factor (Shin et al., 2009). The indirect fluorescent antibody test is profoundly specific but limited due to low sensitivity, requiring fluorescently marked conjugates, and special equipment. Enzyme-linked immunosorbent assay (ELISA) exhibits extraordinary sensitivity, is quantitative, requires minimal effort, and is considered an effective tool for epidemiological investigations of toxoplasmosis. Similarly, the latex agglutination test (LAT) is an effective technique for routine serologic evaluation of T. gondii antibodies (Shin et al., 2009). The accurate detection of toxoplasmosis is crucial to measure in epidemiological settings.

The serological assays are so far successful for large-scale epidemiological studies (Dubey, 2008) to counteraction and control of inherent toxoplasmosis (Jones et al., 2003). Unfortunately, serological screening during antenatal consideration isn’t done regularly in most health centers of Khyber Pakhtunkhwa. For this purpose, public awareness is required to reduce the risk of zoonosis. Therefore, we performed a population-based study to ascertain the prevalence in pregnant females of Khyber Pakhtunkhwa, Pakistan. We also screened anti-T. gondii IgM and IgG antibodies level by using enzyme linked immunosorbent assay (ELISA) and with latex agglutination test.

MATERIALS AND METHODS

Study area, design, and period

The study participants belonged to different districts of Khyber Pakhtunkhwa i.e. Abbottabad, Mansehra, Battagram, Peshawar, and Haripur. The Ethical Committee of Quaid-I-Azam University Islamabad approved the study. Due to the COVID-19 restriction, the data collected from patients during sampling was their age, trimester, and profession. The study included a total of 425 participants comprised of 285 pregnant women and 140 non pregnant women. The study excluded 105 individuals who refused to provide blood samples. Blood sampling was carried out from January 2020 to February 2021 and subjected to LAT, IgG and IgM ELISA tests.

Study population, sample size calculation and blood sampling

The study participants belonged to the diverse background and comprised of females of reproductive age from 15 to 50 years. The sample size was determined by using the formula: n=Z2xp(1-p)/d2 (Daniel, 1995). Where, n is the minimum required sample size, Z is the confidence level at 95% (standard value of 1.96), p is the expected seroprevalence of T. gondii, d is precision or margin error of 5% (standard value 0.05). For each of the visiting patients, 4ml of cubital venous blood was collected using a sterile disposable syringe in a vacutainer tube, serum was extracted and stored at -20 °C.

Serological testing

LAT

Qualitative screening of T. gondii antibodies from serum samples was done by using a commercial kit (Wiener Laboratorios, Argentina) according to manufacturer instructions (Wiener Laboratorios, Argentina).

ELISA

The ELISA was performed to measure the T. gondii IgG and IgG antibodies titers by using commercial kits (Abcam Company, UK) according to manufacturer instruction.

Statistical analysis

Cross-tabulations of sero-status were done with socio-demographic characteristic as summary measures. Chi-square test and univariate logistic analysis were computed to measure the strength of association between toxoplasmosis and associated factors. Odds ratios (OR) were computed and variables resulting in p≤0.05 was considered to be significantly associated with seroprevalence of toxoplasmosis. Statistical analysis was carried out in SPSS version 20.0 and Graph Pad Prism (V. 5) was used for graphical representation of OD values.

RESULTS

Study participants characteristics and overall seroprevalence of T. gondii

A total of 425 women enrolled in the study were divided into four age groups. Most of the women who participated in the study were housewives and the mean age of the participants was 29(±7.47). Of the total studying participants, 285 (67%) were pregnant and 140 (32.9%) were non-pregnant. The total seropositivity of T. gondii predicted by the LAT was found to be 60% (256), 52% (220) with T. gondii IgG ELISA, and 56.26% (238) with IgM ELISA. Table I presents the T. gondii IgG and IgM antibodies titers values (Mean ± SD (Min-Max)).

Latex agglutination test (LAT)

The seroprevalence of T. gondii across socio-demographic characteristics of studied participants is presented in Table II. The results obtained by LAT indicated that out of 256 positive patients maximum seropositivity was observed in Abbottabad district 15% (64), followed by Peshawar 12.9% (55), Mansehra 12.4% (53), and Haripur 11% (47) while the lowest seropositivity

 

Table I. T. gondii IgG and IgM antibodies titre in form of OD Mean ± SD (Min-Max) values among pregnancy status and stages.

Variables

n

IgG antibodies titre

IgM antibodies titre

OD Mean ± SD (Min-Max)

OD Mean ± SD (Min-Max)

Pregnancy status

Pregnant

285

1.22±0.56 (0.19-2.17)

1.06±0.49(0.21-2.17)

Non pregnant

140

1.01±0.59 (0.19-1.99)

0.47±0.50(0.21-1.99)

Stage of pregnancy

First trimester

0.88±0.57 (0.19-2.17)

0.76±0.49(0.19-1.99)

Second trimester

1.23±0.61 (0.21-1.98)

1.01±0.50(0.21-1.99)

Third trimester

1.01±0.59 (0.19-1.91)

1.06±0.49(0.19-2.17)

 

Table II. Seroprevalence and univariate analysis showing association between T. gondii infection rate and sociodemographic factors by using IgG, IgM and LAT assays.

 Characteristics

IgG ELISA

IgM ELISA

LAT

Positive n (%)

OR 95% CI (Range)

p value

Positive n(%)

OR 95% CI (Range)

p value

Positive n (%)

OR 95% CI (Range)

p value

Districts

Abbottabad

60(14.1)

1.36(0.75-2.44)

0.30

51 (12.0)

1.09(0.59-2.00)

0.21

64(15)

1.01(0.55-1.85)

0.95

Mansehra

42(9.8)

0.88(0.48-1.63)

0.70

55 (13)

1.19(0.65-2.15)

0.56

53(12.4)

0.99(0.53-1.85)

0.98

Battagram

31(7.2)

0.89(0.46-1.70)

0.72

43 (10.1)

2.00(1.07-3.73)

0.02*

37(8.7)

0.81(0.42-1.59)

0.55

Peshawar

46(10.8)

1.02(0.56-1.85)

0.94

43 (10.1)

2.18(1.11-4.28)

0.02*

55(12.9)

1.12(0.60-2.09)

0.71

Haripur

41(9.6)

Reference

35 (8.27)

Reference

47(11.0)

Reference

Age in years

15-20

11(2.5)

1.1(0.56-1.85)

0.83

13 (3.07)

1.008(0.56-1.79)

0.97

16(3.76)

1.65(0.66-4.13)

0.28

21-30

130(30.5)

1.85(1.06-3.25)

0.30

60 (14.18)

1.88(0.64-5.50)

0.24

155(36.4)

2.02(1.15-3.56)

0.14

31-40

55(12.9)

2.56(1.33-4.92)

0.00 ***

71 (16.78)

1.10(0.60-2.01)

0.74

56(13.17)

1.75(0.91-3.35)

0.9

41-50

24(5.64)

Reference

25(5.91)

Reference

29(6.82)

Reference

Pregnancy status

Pregnant

164(38.5)

0.49(0.32-0.74)

0.001 ***

147 (34.7)

0.32(0.29- 0.41)

0.001 ***

188(44.2)

0.48(0.32-0.73)

0.001 ***

Non pregnant

56(13.17)

Reference

79(18.6)

Reference

68(16)

Reference

Stage of pregnancy

First trimester

103(36.1)

1.86 (0.85-4.03)

0.11

13.4(4.90)

1.43(0.81-2.53)

0.20

115(40.3)

1.57(0.74-3.33)

0.23

Second trimester

46(16.14)

1.58(0.68-3.66)

0.28

47(17.7)

0.65(0.29-1.45)

0.30

55(12.9)

2.18(0.93-5.10)

0.07

Third trimester

15(5.26)

Reference

88(33.20)

Reference

18(6.31)

Reference

Profession

Housewives

137(32.2)

2.13(1.07-4.25)

0.03*

122 (28.8)

0.45(0.17-1.21)

0.11

159(37.4)

3.74(1.85-7.56)

0.00 ***

Teacher

27(6.3)

1.12 (0.52-2.41)

0.76

35 (8.27)

0.49(0.20-1.19)

0.11

32(7.5)

1.9(0.88-4.10)

0.87

Student

40(9.4)

0.56 (0.30-1.44)

0.29

33 (7.80)

0.58(0.21-1.54)

0.27

49(11.5)

1.06(0.48-2.31)

0.1

Others

16(3.7)

Reference

 

10 (2.36)

Reference

 

16(3.7)

Reference

 

 

was observed in district Battagram of 8.7% (37). However, statistically, no significant (p=0.92) association was observed between infection and districts. The seropositivity was significantly (p=0.001, OR=0.48) higher 44% (188) in pregnant women as compared to non-pregnant women. The women of age group 21-30 years showed higher T. gondii seropositivity of 36.4% (155) and the lowest seropositivity was 3.76% (16) between the age group 12- 20 years. The seropositivity among pregnant women according to trimesters was 40.3% (115) in 1st trimester followed by 12.9% (55) in the 2nd trimester and 6.31% (33) in 3rd trimester. However, the strength of association was not significantly (p>0.05) related to age groups and trimesters. Significantly (p=0.000, χ2=30.28) higher seropositivity of 37.4% was observed in housewives as compared to other professions.

Enzyme-linked immunosorbent assay

Anti-T. gondii IgG ELISA

Table II shows the results of anti-T. gondii IgG ELISA and their association with socio-demographic characteristics. The anti-T. gondii IgG level among different districts of KP indicated higher prevalence in Abbottabad district 14.1%, followed by Peshawar 10.8%, Mansehra 9.8%, Haripur 9.6% (n=41), and Battagram 7.2%, while the difference was not significant (p=0.59). Scatter plot depicting the ranges of OD values obtained among different districts (Fig. 1a). The prevalence of anti- T. gondii IgG was significantly (p=0.001, OR=0.49) higher 38.5% in pregnant women than non-pregnant women. The mean (±SD) values of antibodies titers were 1.59±0.26 among pregnant women (Fig. 1b). Anti-T. gondii IgG level varied significantly (χ2=9.743, p=0.02) among age groups and the highest 30.5% prevalence was found in the 21–30 year group, however, the higher OD values of 1.62±0.21 were obtained among 41-50 years age group (Fig. 1c). High seroprevalence of 36.1% followed by 16.14% and 5.26 % was observed in 1st, 2nd, and 3rd trimesters of pregnancy, while the association was not significant (p=0.27) with OD values of 1.58±0.27 in 1st trimester (Fig. 1d). Significantly (p=0.000; OR=2.13) higher anti-T. gondii IgG prevalence of 32.2% and OD values of 1.56±0.26 were observed in housewives compared to other professions (Fig. 1e).

Anti-T. gondii IgM ELISA

The anti-T. gondii IgM ELISA results across socio-demographic characteristics of studied participants are provided in Table II. The results indicated that significantly (χ2=9.98, p=0.045) highest 13% of anti-T. gondii IgM seroprevalence was obtained in the Mansehra district, followed by Abbottabad, Battagram, Peshawar, and Haripur districts. Mean (±SD) values of anti-T. gondii IgM antibodies titer is given in (Fig. 2a). The significantly (p= 0.001, OR=2.18) higher seroprevalence of 34.7% with an absorbance value of 1.06±0.49 was observed in pregnant women as compared to non-pregnant women (Fig. 2b). Anti- T. gondii IgM prevalence was found 16.78 % highest among 31-40 years group, while high mean OD values of 1.01±0.50 were obtained among 21-30 years age group (Fig. 2c). The anti-T. gondii IgM level was found 33.20% highest in the 3rd trimester of pregnancy with OD values of 1.06±0.49 (Fig. 2d). Among housewives, the seropositivity was 29.53% with an OD of 0.97±0.49 highest compared to other professions (Fig. 2e). The results showed that the strength of association between anti-T. gondii IgM level and age, pregnancy stages, and profession were not significant (p>0.05).

 

 

DISCUSSION

In present study, we investigated prevalence rate of 52-60% T. gondii antibodies in pregnant and childbearing age women from Khyber Pakhtunkhwa, Pakistan. This prevalence is much higher to older studies that found a prevalence of 17.6% from Multan (Nazir et al., 2017), 20.37% in the Pothwar region (Ahmad et al., 2019), and 48% in Kashmir (Aleem et al., 2018). The prevalence rate varies inside the country; these differences could be related to the geographic condition and living standard of participants (Pozio et al., 2003). The geographical location might be an impression of the lifestyle of individuals that makes them more prone to the infection and climate may favor the T. gondii oocysts to sporulate (Gebremedhin et al., 2013). Studies recorded lower toxoplasmosis prevalence among people living in a cold or dry climate (Dubey, 2008). The high prevalence in KP could be related to eating half-cooked or crude meat, raising of the feline is much high, and numerous individuals have high exposure to animal excreta while cultivation and water administration offices are also not well established (Khan et al., 2011).

Studies reported that T. gondii causes moderate infections in non-pregnant ladies, while pregnant women have drastic impacts, especially on the fetus (Liu et al., 2015). Congenital defects, deficits in intrauterine development, and fetal death contribute to both economic and social burdens (Wam et al., 2016). Identification of these infections in both the mother and fetus is the most crucial component of prenatal care. Routine prenatal diagnosis of T. gondii is advised during the first trimester (Zhang et al., 2016). In current study we used most sensitive qualitative and quantitative serological assays for the early detection of toxoplasmosis.

The higher seroprevalence of T. gondii 60% with LAT, 52% and 56% with IgG and IgM ELISA was observed, the results were higher with previous findings reported in in the general population 29.5% by latex agglutination test from Southern Punjab (Tasawar et al., 2012) and 19.3% in pregnant women by Toxo-latex test of District Swabi (Alvi et al., 2014). However, the present results were lower than seroprevalence of T. gondii reported in Ghana, Ethiopia, Europe and the USA (Ayi et al., 2009; Agmas et al., 2015; Pappas et al., 2009). The possible reasons for variations in the prevalence could be due to differences in climatic conditions, mothers’ characteristics i.e. management of cats, educational level, hygienic and feeding practices and type of serological methods used (Agmas et al., 2015; Abamecha and Awel, 2016).

The significantly higher seroprevalence of 34.7%-44.2% was recorded in pregnant women in the current study, consistent with a comparative study from Brazil (Barbosa et al., 2009). T. gondii infections in women of childbearing age vary among countries of the world, India 45% (Sigh and Pandit, 2004), Turkey 43-85% (Tamer et al., 2009), 18.8% in Spain (Gutierrez-Zufiaurre et al., 2004), and 14-25.7% in Sweden (Peterson et al., 2000). This could be attributed due to weak immunity during early pregnancy possess a high risk of getting an infection, lack of awareness about the parasite, its transmission, prevention, and control (Gebremedhin et al., 2013). However, lifestyle such as frequent contact with the soil, eating habits such as consumption of undercooked meat and raw vegetables could be the possible risk factors for getting an infection (Sakikawa et al., 2012; Majid et al., 2016).

The present study recorded 14.18%-36.4% seroprevalence of T. gondii in the 20-30 years age group with ELISA and LAT, agrees with previous investigations (Jittapalapong et al., 2010; Wu et al., 2009; Alvi et al., 2014; Ally and Idris, 2004). The possible reason could be that females of these age groups get married and have more active lifestyles which increase their exposure to the environment with a high density of contamination. During pregnancy might be due to the consumption of poorly washed contaminated fresh fruits and vegetables (Tamer et al., 2009; Abdullah and Mahmood, 2017).

According to trimesters during pregnancy 33.2%-40% seroprevalence was obtained during the 3rd and 1st trimesters, which agrees with previous studies (Wong and Remington, 1994; Ertug et al., 2005; Giannoulis et al., 2008; Abdullah and Mahmood, 2017). Similar to present study, a significantly higher prevalence of 30.5% and 30.7% was recorded in the first and third trimester’s respectively (Alayande et al., 2013). The possible foetal complications during the first trimester due to toxoplasmosis are deformation and even death of the foetus. The present ongoing disease rate in pregnant ladies requires the need of creating antenatal care programs for toxoplasmosis.

The result of the present study predicted high seroprevalence among housewives, showing they have more contact with the parasite than the other professions. A similar finding was recorded from previous studies (Qurashi et al., 2001; Kadhim and Mohammed, 2013). Traditionally, housewives handle and chop meat without gloves, take care of pets, taste uncooked meat while cooking, clean vegetables and fruits, remain engaged in gardening. Oocysts can easily be carried via wind and rain in gardens and exposure to contaminated soil may cause transmission of toxoplasmosis.

In summary high seroprevalence of toxoplasmosis was recorded in pregnant women belonging to 21-30 years age groups during 1st and 3rd trimesters with LAT and ELISA. These findings indicated that toxoplasmosis is a major public health concern in all studied districts of Khyber Pakhtunkhwa, Pakistan. Further studies are required to promote awareness and health education programs to reduce the transmission risk of T. gondii infections.

Acknowledgments

The research work presented in this article is under internal research funding of Quaid-i-Azam University, Islamabad Pakistan.

Statement of conflict of interest

The authors have declared no conflict of interest.

REFERENCES

Abamecha, F. and Awel, H., 2016. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia. BMC Infect. Dis.16: 1-8. https://doi.org/10.1186/s12879-016-1806-6

Abdullah, H.M. and Mahmood, M.A., 2017. Seroprevalence of Toxoplasma gondii among Pregnant Women in Erbil City/Kurdistan Region/Iraq. Polytech. J.7: 54-63. https://doi.org/10.25156/ptj.2017.7.3.47

Agmas, B., Tesfaye, R., and Koye, D.N., 2015. Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia. BMC Res. Notes, 8: 107. https://doi.org/10.1186/s13104-015-1083-2

Ahmad, N., Khan, I.A., Iqbal, Z., Naseem, A.A., Kayani, A.R., Afshan, K. and Qayyum, M., 2019. Seroepidemiology of toxoplasmosis in human population with reference to its zoonotic potential in sub-tropical areas of Pakistan. Pak. Vet. J., 39. https://doi.org/10.29261/pakvetj/2019.017

Alayande, M.O., Edungbola, L.D., Fabiyi, J.P. and Awosan, K.J., 2013. Occurrence of antibody to Toxoplasma infection among pregnant women with obstetric histories and at different trimesters in Sokoto, Northwest Nigeria. Am. J. Res. Commun., 1: 240-247.

Aleem, U., Ullah, S., Qasim, M., and Suliman, M., 2018. Seroprevalence of toxoplasmosis in pregnant women in Matta, Upper Swat, Khyber Pakhtunkhwa, Pakistan. J. Saidu med. Coll.8.

Ally, H. S., and Idris, M., 2004. Frequency of antitoxoplasma antibodies in patients with ocular pathology. J. Ayub med. Coll. Abbottabad, 16: 75-76.

Alvi, F.I., Khan, A.U., Waqar, M., Ahmad, T., Shah, T., Khan, M.I., Ali, N., Faisal, S., Saif, I., Ahmad, W. and Javid, U., 2014. Distribution of Toxoplasma gondii in the pregnant women of district Swabi Khyber Pakhtunkhwa Pakistan. World Appl. Sci. J., 29: 77–79.

Ayi, I., Edu, S.A., Apea-Kubi, K.A., Boamah, D., Bosompem, K.M., and Edoh, D., 2009. Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater accra region of ghana. Ghana med. J.43: 107–114. https://doi.org/10.4314/gmj.v43i3.55325

Barbosa, I.R., Maria, C. and Ferreira, V., 2009. Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil. R. Soc. Trop. Med. Hyg., 103: 377-382. https://doi.org/10.1016/j.trstmh.2008.11.025

Daniel, W.W., 1995. Biostatistics a foundation for analysis in the health science. John Willey and Sons Inc, New York. https://doi.org/10.2307/2533362

Dubey, J.P., 2008. The history of Toxoplasma gondii the first 100 years. J. Eukary. Microbiol., 55: 467-475. https://doi.org/10.1111/j.1550-7408.2008.00345.x

Ertug, S., Okyay, P., Turkmen, M. and Yuksel, H., 2005. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Publ. Hlth.5: 1-6. https://doi.org/10.1186/1471-2458-5-66

Gebremedhin, E.Z., Abebe, A.H., Tessema, T.S., Tullu, K.D., Medhin, G., Vitale, M. and Dorny, P., 2013. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect. Dis., 13: 1-9. https://doi.org/10.1186/1471-2334-13-101

Giannoulis, C., Zournatzi, B., Giomisi, A., Diza, E., and Tzafettas, I., 2008. Toxoplasmosis during pregnancy: A case report and review of the literature. Hippokratia12: 139.

Guruz, A.Y., Ok, U.Z., and Korkmar, M., 1996. Assessment of latex indirect agglutination test (Toxolatex Fumouze) for the detection of Toxoplasma specific antibody in human sera in Turkey. J. Egypt. Soc. Parasitol., 26: 376-384.

Gutiérrez-Zufiaurre, N., Sánchez-Hernández, J., Muñoz, S., Marín, R., Delgado, N., Sáenz, M.C., Muñoz-Bellido, J.L. and García-Rodríguez, J.A., 2004. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm. Infecc. Microbiol. Clin.22: 512-516. https://doi.org/10.1157/13067618

Hadi, H.S., Kadhim, R.A. and Al-Mammori, R.T., 2016. Seroepidemiological aspects for Toxoplasma gondii infection in women of Qadisiyah province, Iraq. Int. J. Pharm. Tech. Res., 9: 252-259.

Jittapalapong, S., Inpankaew, T., Pinyopanuwat, N., Chimnoi, W., Kengradomkij, C., Wongnarkpet, S. and Sukthana, Y., 2010. Epidemiology of Toxoplasma gondii infection of stray cats in Bangkok, Thailand. Southe. A. J. Trop. Med. Publi. Hlth., 41:13-18.

Jones, J.L., Lopez, A., and Wilson, M., 2003. Congenital toxoplasmosis. Am. Fam. Phys., 67: 2131-2138.

Kadhim, R.A., and Mohammed, H., 2013. Seroprevalence of Toxoplasma gondii antibodies among pregnant women in Babylon Province, Iraq. Kufa J. Nurs. Sci., 3:153-159.

Khan, S.N., Khan, S., Ayaz, S., Jan, A.H., Jehangir, S., Attaullah, S., Ali, I. and Shams, S., 2011. Seroprevalance and risk factors of toxoplasmosis among pregnant women in District Kohat, Khyber Pakhtunkhwa, Pakistan. World appl. Sci. J.14: 1032-1036.

Koneman, E.W., Allen, S.D., Janda, W.M., Schereckenberger, P.C. and Winn, W.C., 2004. Introduction diagnostic microbiology. J.B. Lippincott Co., Philadelphia, PA, USA.

Liu, Q., Wang, Z.D., Huang, S.Y. and Zhu, X.Q., 2015. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit. Vectors, 8: 1-14. https://doi.org/10.1186/s13071-015-0902-6

Majid, A., Khan, S., Jan, A.H., Taib, M., Adnan, M., Ali, I. and Khan, S.N., 2016. Chronic toxoplasmosis and possible risk factors associated with pregnant women in Khyber Pakhtunkhwa. Biotechnol. Biotechnol. Equip.30: 733-736. https://doi.org/10.1080/13102818.2016.1175966

Nazir, M.M., Akhtar, M., Maqbool, A., Waheed, A., Sajid, M.A., Ali, M.A., Oneeb, M., Alam, M.A., Ahmad, A.N., Nazir, N. and Fatima, S., 2017. Antibody prevalence and risk factors for Toxoplasma gondii infection in women from Multan, Pakistan. Zoon. Publ. Hlth.64: 537-542. https://doi.org/10.1111/zph.12336

Pappas, G., Roussos, N. and Falagas, M.E., 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol.39: 1385-1394. https://doi.org/10.1016/j.ijpara.2009.04.003

Petersson, K., Stray-Pedersen, B., Malm, G., Forsgren, M. and Evengård, B., 2000. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet. Gynecol. Scand.79: 824-829. https://doi.org/10.1034/j.1600-0412.2000.079010824.x

Pozio, E., Gomez, M.M.A. and Dupouy-Camet, J., 2003. Clinical aspects, diagnosis and treatment of trichinellosis. Exp. Rev. Anti-infect. Ther., 1: 471-482. https://doi.org/10.1586/14787210.1.3.471

Qurashi, A.R., Ghandour, A.M., Obied, O.E., Al-Mulhim, A. and Makki, S.M., 2001. Seroepidemiological study of Toxoplasma gondii infection in the human population in the Eastern Region. Saudi med. J.22: 13-18.

Rehman, F., Shah, M., Ali, A., Rapisarda, A.M.C. and Cianci, A., 2021. Seroprevalence and risk factors of Toxoplasma gondii infection in women with recurrent fetal loss from the province of khyber Pakhtunkhwa, Pakistan. J. Neonatal-Perinatal Med.14: 115-121. https://doi.org/10.3233/NPM-190323

Robert-Gangneux, F. and Dardé, M.L., 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev., 25: 264-296. https://doi.org/10.1128/CMR.05013-11

Sakikawa, M., Noda, S., Hanaoka, M., Nakayama, H., Hojo, S., Kakinoki, S., Nakata, M., Yasuda, T., Ikenoue, T., and Kojima, T., 2012. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin. Vaccine Immunol.19: 365-367. https://doi.org/10.1128/CVI.05486-11

Shahzad, A., Amjad, Z., Khan, T. M., Maalik, A., Iftikhar, A., Khan, I. and Haroon, A., 2020. Occurrence of Toxoplasma gondii antibodies and associated risk factors in women in selected districts of Punjab province, Pakistan. Parasitology, 147: 1133-1139. https://doi.org/10.1017/S0031182020000967

Shin, D.W., Cha, D.Y., Hua, Q.J., Cha, G.H. and Lee, Y.H., 2009. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J. Parasitol., 47: 125. https://doi.org/10.3347/kjp.2009.47.2.125

Singh, S., and Pandit, A.J., 2004. Incidence and prevalence of toxoplasmosis in Indian pregnant women: A prospective study. Am. J. Reprod. Immunol.52: 276-283. https://doi.org/10.1111/j.1600-0897.2004.00222.x

Sukthana, Y., Chintana, T., Supatanapong, W., Siripan, C., Lekkla, A. and Cheabchalrad, R., 2001. Predictive value of latex agglutination test in serological screening for Toxoplasma gondii. Southeast Asian J. Trop. Med. Publ. Hlth.32: 314-318.

Tamer, G.S., Dundar, D. and Caliskan, E., 2009. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin. Invest. Med., pp. E43-E47. https://doi.org/10.25011/cim.v32i1.5086

Tasawar, Z., Aziz, F., Lashari, M.H., Shafi, S., Ahmad, M., Lal, V. and Hayat, C.S., 2012. Seroprevalence of Human toxoplasmosis in southern Punjab, Pakistan. Pak. J. Life Soc. Sci., 10: 48-52.

Tenter, A.M., Heckeroth, A.R. and Weiss, L.M., 2000. Toxoplasma gondii from animals to humans. Int. J. Parasitol., 30: 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7

Varella, I.S., Canti, I.C., Santos, B.R., Coppini, A.Z., Argondizzo, L.C., Tonin, C. and Wagner, M.B., 2009. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother to child transmission rate in a public hospital in South Brazil. Mem. Inst. Oswaldo Cruz, 104: 383-388. https://doi.org/10.1590/S0074-02762009000200037

Wam, E.C., Sama, L.F., Ali, I.M., Ebile, W.A., Aghangu, L.A. and Tume, C.B., 2016. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon. BMC Res. Notes9: 1-8. https://doi.org/10.1186/s13104-016-2206-0

Weiss, L.M., and Dubey, J.P., 2009. Toxoplasmosis: A history of clinical observations. Int. J. Parasitol., 39: 895-901. https://doi.org/10.1016/j.ijpara.2009.02.004

Wong, S.Y., and Remington, J.S., 1994. Toxoplasmosis in pregnancy. Clin. Infect. Dis., pp. 853-861. https://doi.org/10.1093/clinids/18.6.853

Wu, K., Chen, X.G., Li, H., Yan, H., Yang, P.L., Lun, Z.R. and Zhu, X.Q., 2009. Diagnosis of human toxoplasmosis by using the recombinant truncated surface antigen 1 of Toxoplasma gondiiDiagn. Microbiol. Infect. Dis.64: 261-266. https://doi.org/10.1016/j.diagmicrobio.2009.02.009

Zhang, K., Lin, G., Han, Y. and Li, J., 2016. Serological diagnosis of toxoplasmosis and standardization. Clin. Chim. Acta461: 83-89. https://doi.org/10.1016/j.cca.2016.07.018

To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology

April

Pakistan J. Zool., Vol. 56, Iss. 2, pp. 503-1000

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe